The chemical substance with the name "(3S)-3-[(2S,3R)-3-(acetyloxy)-1-L-valylpyrrolidin-2-yl]-3-{[N-(2-methylbutanoyl)-L-phenylalanyl]oxy}propanoic acid" and CAS number "37878-19-6" is a complex organic compound characterized by its specific stereochemistry and functional groups. It features a propanoic acid backbone, which is modified by the presence of an acetyloxy group and a pyrrolidine ring, indicating potential biological activity. The compound also contains amino acid residues, specifically L-valine and L-phenylalanine, which suggest that it may interact with biological systems, possibly as a peptide or a peptide-like molecule. The presence of multiple chiral centers implies that it exists in specific stereoisomeric forms, which can significantly influence its pharmacological properties. Additionally, the compound's structure suggests potential applications in medicinal chemistry, particularly in the development of therapeutics targeting specific biological pathways. Overall, its intricate structure and functional groups highlight its potential significance in biochemical research and drug development.

(3S)-3-[(2S,3R)-3-(acetyloxy)-1-L-valylpyrrolidin-2-yl]-3-{[N-(2-methylbutanoyl)-L-phenylalanyl]oxy}propanoic acid

37878-19-6: The chemical substance with the name "(3S)-3-[(2S,3R)-3-(acetyloxy)-1-L-valylpyrrolidin-2-yl]-3-{[N-(2-methylbutanoyl)-L-phenylalanyl]oxy}propanoic acid" and CAS number "37878-19-6" is a complex organic compound characterized by its specific stereochemistry and functional groups. It features a propanoic acid backbone, which is modified by the presence of an acetyloxy group and a pyrrolidine ring, indicating potential biological activity. The compound also contains amino acid residues, specifically L-valine and L-phenylalanine, which suggest that it may interact with biological systems, possibly as a peptide or a peptide-like molecule. The presence of multiple chiral centers implies that it exists in specific stereoisomeric forms, which can significantly influence its pharmacological properties. Additionally, the compound's structure suggests potential applications in medicinal chemistry, particularly in the development of therapeutics targeting specific biological pathways. Overall, its intricate structure and functional groups highlight its potential significance in biochemical research and drug development.

Detoxin D1 is a selective blasticidin S antagonist.

CAS 37878-19-6

(3S)-3-[(2S,3R)-3-(acetyloxy)-1-L-valylpyrrolidin-2-yl]-3-{[N-(2-methylbutanoyl)-L-phenylalanyl]oxy}propanoic acid

Detoxin D1

Ref: TM-T25314